A Cascade ROS Nanoamplifier for Enhanced Sono‐Chemodynamic Therapy of Osteosarcoma
Advanced Healthcare Materials · 2026-03 · 15 (12)
DOI: 10.1002/adhm.202504957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.01.2026. Verfasst von Panfeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Changhai Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Osteosarcoma, Reactive Oxygen Species, Ultrasonic Therapy, Bone Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
The cascade amplification of reactive oxygen species (ROS) production plays a vital role in enhancing the effectiveness of sonodynamic/chemodynamic therapy (SDT/CDT) for osteosarcoma. Nevertheless, the currently developed sonosensitizers and nanozymes face challenges such as low ROS production efficiency, poor stability, and limitations imposed by the unfavorable tumor microenvironment (TME). Herein, we report a unique strategy for amplifying ROS yield by combining the augmentation of sonosensitizer/nanozyme activity with the regulation of TME. A heterojunction with bandgap matching is created by combining RuO 2 nanozymes and Zr‐based metal‐organic frameworks (Zr‐MOF) to obtain the enhanced sonodynamic and chemodynamic activities owing to the improved electron–hole separation kinetics. RuO 2 nanozymes serve as an auxiliary semiconductor to sensitize Zr‐MOF, suppressing the recombination of US‐activated electron–hole pairs and enhancing the multienzyme‐mimic activity of Zr‐MOF by accelerating electron transfer efficiency. By boosting SDT/CDT performances, depleting GSH, and alleviating tumor hypoxia, RuO 2 @Zr‐MOF achieves cascade amplification of ROS production. With the combination of intravenous injection of RuO 2 @Zr‐MOF and US irradiation of tumor tissues, the heterojunction nanoplatforms achieve total elimination of tumor tissues with no chance of recurrence. This work showcases the potential of RuO 2 nanozymes as supplementary semiconductors in the sensitization of sonosensitizers, offering novel insights for heterojunction engineering in combating the refractory osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Changhai Hospital, Naval Medical University, Shanghai, China.
- Burn and Wound Repair Center, Changhai Hospital, Naval Medical University, Shanghai, China.
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai, China.
ORCID-Profile: Bijiang Geng
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Wang, P., Wang, H., Xu, D., Hu, J., Geng, B., Chen, K., & Wu, D. (2026). A Cascade ROS Nanoamplifier for Enhanced Sono‐Chemodynamic Therapy of Osteosarcoma. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202504957
Vancouver
Wang P, Wang H, Xu D, Hu J, Geng B, Chen K, et al. A Cascade ROS Nanoamplifier for Enhanced Sono‐Chemodynamic Therapy of Osteosarcoma. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202504957
BibTeX
@article{Wang2026,
author = {Wang, Panfeng and Wang, Hongrui and Xu, Dayuan and Hu, Jinyan and Geng, Bijiang and Chen, Kai and Wu, Dajiang},
title = {A Cascade ROS Nanoamplifier for Enhanced Sono‐Chemodynamic Therapy of Osteosarcoma},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {12},
doi = {10.1002/adhm.202504957}
}
EUVIMED